Latest


Zydus settles case with Upsher-Smith on Qudexy

  •   Fri, Jan 13 2017 02:36:44 PM

Ahmedabad, Jan 13 (IANS): Pharmaceuticals company Cadila Healthcare and its subsidiary Zydus Pharmaceuticals (US) have finalised an agreement with Upsher-Smith Laboratories, a regulatory filing said here on Friday.

This would settle all outstanding patent litigation related to Qudexy XR (topiramate) extended-release capsules. 

"Under the terms of the agreement, Upsher-Smith grants Zydus a licence to market Zydus' generic version of Qudexy XR beginning March 19, 2020, or earlier under certain circumstances," the filing with the BSE said.

However, other terms of the settlement were not disclosed.
  

Top Stories

Mangaluru: Luxury residential apartment ‘Divine Grace’ inaugurated

  •   12 hours ago    1

Leave a Comment

Title: Zydus settles case with Upsher-Smith on Qudexy



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.

You might also like